Clinical Outcomes of Mitral Valve Surgery in Atrial Functional Mitral Regurgitation in the REVEAL-AFMR Registry
JAMA Network Open · 15.08.2024 · 7 (8) · e2428032
DOI: 10.1001/jamanetworkopen.2024.28032 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift JAMA Network Open, online erschienen am 15.08.2024. Verfasst von Nobuyuki Kagiyama und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Heart Atria, Mitral Valve, Mitral Valve Insufficiency, Registries. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance The characteristics and treatment strategies of atrial functional mitral regurgitation (AFMR) are poorly understood.
Objective
To investigate the prevalence, clinical characteristics, and outcomes of mitral valve (MV) surgery in AFMR. Design, Setting, and Participants This retrospective cohort study, called the Real-World Observational Study for Investigating the Prevalence and Therapeutic Options for Atrial Functional Mitral Regurgitation (REVEAL-AFMR), was conducted across 26 Japanese centers (17 university hospitals, 1 national center, 3 public hospitals, and 5 private hospitals). All transthoracic echocardiography procedures performed from January 1 to December 31, 2019, were reviewed to enroll adult patients (aged ≥20 years) with moderate or severe AFMR, defined by preserved left ventricular function, a dilated left atrium, and an absence of degenerative valvular changes. Data were analyzed from May 8, 2023, to May 16, 2024. Exposures Mitral valve surgery, with or without tricuspid valve intervention. Main Outcomes and Measures The primary composite outcome included heart failure hospitalization and all-cause mortality.
Results
In 177 235 patients who underwent echocardiography, 8867 had moderate or severe MR. Within this group, 1007 (11.4%) were diagnosed with AFMR (mean [SD] age, 77.8 [9.5] years; 55.7% female), of whom 807 (80.1%) had atrial fibrillation. Of these patients, 113 underwent MV surgery, with 92 (81.4%) receiving concurrent tricuspid valve surgery. Patients who underwent surgery were younger but had more severe MR (57.5% [n = 65] vs 9.4% [n = 84]; P < .001), a larger mean (SD) left atrial volume index (152.5 [97.8] mL/m 2 vs 87.7 [53.1] mL/m 2 ; P < .001), and a higher prevalence of heart failure (according to the New York Heart Association class III [marked limitation of physical activity] or class IV [symptoms of heart failure at rest], 26.5% [n = 30] vs 9.3% [n = 83]; P < .001) than those who remained under medical therapy. During a median follow-up of 1050 days (IQR, 741-1188 days), 286 patients (28.4%) experienced the primary outcome. Despite a more severe disease status, only the surgical group showed a decrease in natriuretic peptide levels at follow-up and had a significantly lower rate of the primary outcome (3-year event rates were 18.3% vs 33.3%; log-rank, P = .03). Statistical adjustments did not alter these findings. Conclusions and Relevance The findings of this cohort study suggest that in patients with AFMR, who were typically older and predominantly had atrial fibrillation, MV surgery was associated with lower rates of adverse clinical outcomes. Future studies are warranted to investigate a possible causal relationship to better regulate cardiovascular medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
- Department of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Suita, Japan.
- Department of Cardiology, St Marianna University School of Medicine, Kawasaki, Japan.
- Department of Cardiology, Tokai University School of Medicine, Isehara, Japan.
- Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
- Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Zitieren
APA
Kagiyama, N., Kaneko, T., Amano, M., Sato, Y., Ohno, Y., Obokata, M., Sato, K., Okada, T., Hoshino, N., Yamashita, K., Katsuta, Y., Izumi, Y., Ota, M., Mochizuki, Y., Sengoku, K., Sasaki, S., Nagura, F., Nomura, N., Nishikawa, R., …, & Abe, Y. (2024). Clinical Outcomes of Mitral Valve Surgery in Atrial Functional Mitral Regurgitation in the REVEAL-AFMR Registry. JAMA Network Open, 7(8), e2428032. https://doi.org/10.1001/jamanetworkopen.2024.28032
Vancouver
Kagiyama N, Kaneko T, Amano M, Sato Y, Ohno Y, Obokata M, et al. Clinical Outcomes of Mitral Valve Surgery in Atrial Functional Mitral Regurgitation in the REVEAL-AFMR Registry. JAMA Network Open. 2024;7(8):e2428032. doi:10.1001/jamanetworkopen.2024.28032
BibTeX
@article{Kagiyama2024,
author = {Kagiyama, Nobuyuki and Kaneko, Tomohiro and Amano, Masashi and Sato, Yukio and Ohno, Yohei and Obokata, Masaru and Sato, Kimi and Okada, Taiji and Hoshino, Naoki and Yamashita, Kentaro and Katsuta, Yuko and Izumi, Yuki and Ota, Mitsuhiko and Mochizuki, Yasuhide and Sengoku, Kaoruko and Sasaki, Shunsuke and Nagura, Fukuko and Nomura, Nanaka and Nishikawa, Ryo and Kato, Nahoko and Sakamoto, Takahiro and Eguchi, Noriko and Senoo, Maiko and Kitano, Mariko and Takaya, Yoichi and Saijo, Yoshihito and Tanaka, Hidekazu and Nochioka, Kotaro and Omori, Nami and Tabata, Minoru and Minamino, Tohru and Hirose, Naoki and Morita, Kojiro and Machino-Ohtsuka, Tomoko and Delgado, Victoria and Abe, Yukio},
title = {Clinical Outcomes of Mitral Valve Surgery in Atrial Functional Mitral Regurgitation in the REVEAL-AFMR Registry},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {8},
pages = {e2428032},
doi = {10.1001/jamanetworkopen.2024.28032}
}
EUVIMED